Clinical Trial Detail

NCT ID NCT03480646
Title ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Constellation Pharmaceuticals
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Abiraterone + CPI-1205 + Prednisone

CPI-1205 + Enzalutamide

Age Groups: senior adult

No variant requirements are available.